S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PHXM PHAXIAM Therapeutics SA

3.10

0.00 (0.00%)

05 Jun 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

PHAXIAM Therapeutics (NASDAQ:PHXM)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more PHAXIAM Therapeutics Charts.

PHAXIAM Therapeutics (NASDAQ:PHXM)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more PHAXIAM Therapeutics Charts.

PHAXIAM Therapeutics SA News

Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]
Monday 11 March 2024 (3 months ago) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
Monday 11 March 2024 (3 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 6 March 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Tuesday 5 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 21 February 2024 (3 months ago) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
Wednesday 21 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Saturday 20 January 2024 (5 months ago) • Edgar (US Regulatory)

PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
Friday 19 January 2024 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 16 November 2023 (7 months ago) • Edgar (US Regulatory)

PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023
Wednesday 15 November 2023 (7 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 26 October 2023 (7 months ago) • Edgar (US Regulatory)

More PHAXIAM Therapeutics SA News Articles

BlackRock Large Cap Core...

NLBNPIT1VC86 20991231 10...

Mitsu Hc Cap.27

DAXsector Automobile Per...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions